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1. Introduction 
Tunicamycin, a N-acetylglucosamine containing 
antibiotic from Streptomyces lysosuperijkus was 
originally isolated on the basis of its antiviral 
activity [1,2 ] . Subsequent work demonstrated that 
tunicamycin selectively interferes with glycoprotein 
biosynthesis. This has been shown for the suppression 
of virus membrane glycoproteins [3,4 ] . In Saccharo- 
myces cerevisiae the formation of the external manno- 
proteins invertase, acid phosphatase and cell wall 
mannan as well as that of the vacuolar carboxy- 
peptidase Y is stopped in the presence of tunicamycin 
[5,6]. In contrast to this the synthesis of non-glyco- 
sylated proteins or wall polysaccharides is not 
influenced [ 5,6] . 
There are several ines of evidence indicating that 
tunicamycin exerts its effect by blocking the attach- 
ment of the carbohydrate residue to the protein 
[3,4,7] . Polyprenol-bound sugar phosphates function 
as intermediates in glycosyl transfer [8,9] and it has 
indeed been observed that the transfer of N-acetyl- 
glucosamine to dolichylphosphate is sensitive to 
tunicamycin as examined in microsomal fractions 
from calf liver and chick embryo [lo,1 1 ] . The 
question, however, has been left unanswered so far, 
whether the transfer of only the first or also the 
second GlcNAc as well as further glycosyl groups to 
dolichol is prevented by tunicamycin. 
A membrane fraction from S. cerevisiae catalyzes 
in vitro the following reaction sequence, which is 
Abbreviations: Dol-PP-GlcNAc, dolichyl diphosphate N- 
acetylglucosamine; Dal-PP-(GlcNAc),, dolichyl diphosphate 
di-Nacetylchitobiose 
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supposed to be involved in the formation of manno- 
proteins [ 121 
1. UDP-GlcNAc + Dol-P - 
Dol-PP-GlciVAc + UMP 
2. UDP-GlcJVAc t Dol-PP-GlcNAc - 
Do~-PP(G~~FVAC)~ + UDP 
3. GDP-Man t Dol-PP-(GlcNAc)a --+ 
Dol-PP(GlcNAc)a -Man + GDP. 
It will be shown that tunicamycin inhibits the 
transfer of GlcNAc to dolichol phosphate 
(reaction 1) also in yeast. In addition it will be 
demonstrated that neither reaction 2 or 3 at all 
sensitive to the antibiotic. 
2. Materials and method 
The membrane fraction was prepared from S. cere- 
visiae (strain 66.24, Fleischman Laboratories) as 
previously described [ 131. Transfer of N-acetylgluco- 
samine from UDP-GlcNAc to Dol-P has been tested 
in the following way: 5 I.cg Dol-P was mixed with 
2 pmol MgEDTA and dried under nitrogen. 50 mM 
Tris-HCl (pH 7.5), 10 mM MgClz, 0.17% Triton 
X-100,4.76 PM [14C] UDP-GlcNAc (spec.act. 300 Ci/ 
mol, Amersham) and membrane preparation (0.06 mg 
protein) were added to a total volume of 0.07 ml. 
Incubations were carried out at 23°C for various 
intervals. Labelled lipids were extracted and washed 
as described [ 141. 
Thin layer chromatography was performed on 
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Silica Gel G (Merck) in the solvent system chloroform/ 
methanol/water (65:25:4). Labelled components 
were located by radiochromatography with Agfa 
Gevaert Osray T4 film. Radioactive spots were scraped 
off the plates and counted by liquid scintillation in 
dioxane. 
3. Results and discussion 
Yeast membranes incubated with [14C] UDP- 
GlcNAc incorporate radioactivity into a lipophilic 
fraction, which separated into four compounds upon 
TLC (fig.1). Only peaks III and IV can be stimulated 
by the addition of exogenous Dol-P to the reaction 
mixture and have previously been identified as Dol- 
PP-GlcNAc and Dol-PP-(GlcNAc)a, respectively, [ 121. 
Peak I and peak II (the latter is difficult to separate 
from peak III) have not been identified up to now. 
Their nature, however, seems to be different from 
that of a polyprenol derivative, since mild alkaline 
saponification (0.1 N NaOH, 37°C 15 min), which 
brings about deacylation of glyceroglycolipids 
converted more than 90% of the radioactivity water- 
soluble. 
Time [mm) Time (mini 
Fig.2. Time course of incorporation of [N-acetyl-‘4C]- 
glucosamine from [UDP-‘4C]GlcNAc into glycolipids. A: 
peak I (a,~), peak II (=,c); B: peak III corresponding to Dol- 
PP-GlcfVAc (*,o), peak IV corresponding to Dol-PP-GlcNAc 
(~,a). Closed circles without, open circles with tunicamycin 
(7 pg/ml). Experiments were carried out as described under 
Materials and methods. 
PP-GlcZVAc and Do~-PP(G~uVAC)~, but did not affect 
the synthesis of both the other radioactive compounds 
peak I and II. 
The effect of tunicamycin on the formation of the The dependence of the inhibition of GlcNAc- 
radioactive glycolipids is shown in fig.1 and 2. The transfer on the concentration to tunicamycin was 
antibiotic completely inhibited the formation of Dol- determined after an incubation for 15 min (tig.3). 
Dol-PP-GlcNAc 
Dol -PP-(GlcNAcJ2 
A El Peak 
I 
II 
III 
IV 
Origin 
Fig.1. Thin layer chromatography of [N-acetyl-“C]glucosamine lipid synthesized from [UDP-“ClGlcNAc. Incubations were 
carried out as described in Materials and methods in the absence (A) or in the presence (B,C) of exogenous Dol-P. Experiment C 
contained in addition tunicamycin (7 ug/mI). 
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isolated radioactive glycolipid fraction (containing 
peak I-IV) with unlabelled UDP-GlcNAc led to a 
decrease in radioactive Dol-PP-GlcNAc and a corre- 
sponding increase in the chitobiose containing lipid. 
The increase in radioactivity in peak IV in the 
presence of tunicamycin (expt. C) indicates that the 
antibiotic does not interfere with the transfer of the 
second GlcNAc to Dol-PP-GlcNAc. When GDP-Man is 
present in addition to UDP-GlcJVAc, Dol-PP- 
(G~cNAc)~ acts as acceptor for the formation of 
Dol-PP-(GlcNAc)z-Man (expt. D). Also this mannosyl 
1 2 3 4 5 6 7 
TM concentration fpg/ml) 
Fig.3. Dose response of tunicamycin on the formation of 
[ ‘?Z] GlcNAc labelled lipids. Incubations were carried out 
transfer is not affected by tunicamycin (expt. E). 
The results presented in this paper show that in 
yeast, too, tunicamycin is a very potent inhibitor for 
the biosynthesis of dolichyl diphosphate-bound 
GlcNAc derivatives. Moreover, the inhibitors action 
under standard conditions with various amounts of tunic- 
amycin: peak I (o-o), peak II (m-m), Dol-PP-GlcNAc (A-A), 
Dol-PP-(GlcNAc), (A-A). 
The antibiotic is very potent SO%; inhibition is 
achieved at a concentration of about 0.3 MS/ml. 
It has previously been demonstrated [ 121 that 
Dol-PP-GlcNAc is the precursor for the formation of 
Do~-PP-(G~~NAc)~. From the data obtained so far, it 
cannot be decided, therefore, whether tunicamycin 
blocks the formation of peak IV directly or only on 
account of a shortage of its precursor Dol-PP-GlcNAc. 
The following experiment was carried out, to decide 
between these two possibilities. Reincubation of the 
of tunicamycin seems to be restricted exclusively to 
the transfer of that GlcNAc moiety which is directly 
linked to the lipid component, whereas further 
glycosyl transfer reactions leading to lipid-linked 
oligosaccharides are not affected. The specificity of 
the antibiotic is also indicated by the fact that the 
synthesis of peak I and II is not influenced. In 
addition no effect of tunicamycin has been observed 
for the synthesis of polyprenyl phosphate-linked 
mannose and galactose [lo,1 11, whereas GlcJVAc- 
transfer to undecaprenyl phosphate in Bacillus 
subtilis again is inhibited by the antibiotic [ 1 S J . 
As indicated by the observations of Kuo and 
Lampen [S ] , tunicamycin will be a valuable tool in 
Table 1 
Influence of tunicamycin on the formation of Dol-PP-di-N-acetylchitobiose and dolichyl diphosphate-bound oligosaccharide 
Expt. Incubation conditions Radioactivity (cpm) found ina 
Dol-PP- Dol-PP- Dol-PP- 
ClcNAc (GlcNAc), (GlcNAc),-Man 
A “C-Labelled glycolipid (control) 1710 5400 0 
B + UDP-GicNAc 180 7020 0 
C + UDP-GlcNAc + tunicamycin 216 6966 0 
D + UDP-GlcNAc + GDP-Man 405 180 6300 
E + UDP-GlcNAc + GDP-Man + tunicamycin 387 207 6120 
aPeak I and II are not listed; their radioactivity remained completely unchanged uring all experiments 
‘%Labelled glycolipid fraction (containing peak I-IV) was synthesized in a scaled up reaction mixture according to Materials 
and methods, extracted and used for the following experiments. “C-Labelled glycolipid (14 000 cpm) was dried under a stream 
of nitrogen and the following components were added in a finalvolume of 0.07 ml: 28 mM Tris-HCI (pH 8), 10 mM MgCl,, 0.17% 
Triton X-100, 0.06 mg protein (particulate fraction), 1 mM UDP-GlcNAc (expt. B-E), 1 mM GDP-Man (expt. D,E) and where 
indicated tunicamycin (7 rg/ml). After incubation for 120 min the lipids were extracted again, washed and analyzed by TLC. 
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studies of secretion and the possible involvement of 
glycosylation reactions in this process. Knowing the 
very specific site of action of tunicamycin should be 
helpful when applying the antibiotic. 
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